TITLE

Today's Transactions Pfizer Acquires NextWave Pharmaceuticals for up to $700M

AUTHOR(S)
COLLINS, ALLISON
PUB. DATE
October 2012
SOURCE
Mergers & Acquisitions Report;10/29/2012, Vol. 25 Issue 44, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the acquisition of privately-held specialty pharmaceutical firm NextWave Pharmaceuticals by Pfizer Inc.
ACCESSION #
82988323

 

Related Articles

  • Takeda Acquires LigoCyte Pharma.  // Contract Pharma;Nov/Dec2012, Vol. 14 Issue 9, p94 

    The article offers information related to pharmaceutical industry acquisition. It says that LigoCyte Pharmaceuticals Inc. will be acquired by Takeda Pharmaceutical Co. Ltd. as part of the company's expansion for its vaccine business. It mentions that Pfizer Inc. has entered an option and merger...

  • Pharma: Other News To Note.  // BioWorld Today;11/29/2012, Vol. 23 Issue 231, p6 

    This section offers news briefs related to the pharmaceutical industry, including Forest Laboratories Inc.'s submission of a new drug application for cariprazine, and Pfizer Inc.'s acquisition of NextWave Pharmaceuticals Inc.

  • Today's Transactions: Pfizer Closes on NextWave Purchase, Could Pay Up to $700M. COLLINS, ALLISON // Mergers & Acquisitions Report;12/3/2012, Vol. 25 Issue 49, p17 

    The article reports on the completion of acquisition of specialty pharmaceutical firm NextWave Pharmaceuticals Inc. by New York-based pharmaceutical manufacturer Pfizer Inc. worth 700 million dollars.

  • Pfizer Forays into ADHD Market by Exercising Option to Acquire NextWave Pharmaceuticals. Cartwright, Heather // PharmaDeals Review;2012, Vol. 2012 Issue 11, p143 

    In a deal worth up to US$680 M, Pfizer is to acquire NextWave Pharmaceuticals, a speciality pharmaceutical company that won US FDA approval in September 2012 for Quillivant XRâ„¢ (methylphenidate hydrochloride), a once-daily, extended-release formulation of liquid methylphenidate for...

  • Pfizer in Deal to Acquire NextWave for $700 Million.  // MondayMorning;10/29/2012, Vol. 20 Issue 41, p1 

    The article reports that New York based Pfizer Inc. agreed to pay 700 million U.S. dollars to buy NextWave Pharmaceuticals Inc. It mentions that their deal includes an initial 255 million U.S. dollars and 425 million U.S. dollars in milestone payments depending on the profit generated by...

  • Pfizer's other strategy. Messina, Judith // Crain's New York Business;7/22/2002, Vol. 18 Issue 29, p31 

    Reports the acquisition of Pharmacia Corp. by Pfizer Inc. in New York. Strategies of the drugmakers for growth; Alliances of both companies with biotechnology and technology companies; Development of sales and marketing machine; Percentage of the revenue growth of the industry.

  • Pfizer antes up $60 billion for Pharmacia. Ukens, Carol // Drug Topics;8/5/2002, Vol. 146 Issue 15, p22 

    Reports the plans of New York City-based pharmaceutical firm Pfizer to acquire Pharmacia in an all-stock deal. Consequences of a possible merger; Implications for competitors; Discussion on the benefits of Pfizer from its takeover of Warner Lambert.

  • Maryland lawmakers press Pfizer to rule out layoffs in merger. Al-Faruque, Ferdous // Hill;5/14/2014, Vol. 21 Issue 57, p14 

    The article reports that six Democratic members from Maryland called on pharmaceutical company Pfizer Inc. to assure its employees that they would be able to keep their jobs if merger with British drugmaker AstraZeneca will push through.

  • the engineer poll.  // Engineer (00137758);Jun2014, Vol. 296 Issue 7852, p18 

    The article reports on the results of a survey about the proposed takeover of British-Swedish pharmaceutical firm AstraZeneca plc by American pharmaceutical firm Pfizer and mentions topics like mergers and acquisition, corporate tax rates, and pharmaceutical industry.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics